211 related articles for article (PubMed ID: 17499541)
1. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
[TBL] [Abstract][Full Text] [Related]
2. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003.
Eliasson B; Cederholm J; Nilsson P; Gudbjörnsdóttir S;
Diabet Med; 2005 Oct; 22(10):1420-6. PubMed ID: 16176206
[TBL] [Abstract][Full Text] [Related]
3. The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.
Gudbjörnsdottir S; Cederholm J; Nilsson PM; Eliasson B;
Diabetes Care; 2003 Apr; 26(4):1270-6. PubMed ID: 12663609
[TBL] [Abstract][Full Text] [Related]
4. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
5. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres.
Sundquist K; Chaikiat A; León VR; Johansson SE; Sundquist J
Diabetes Metab Res Rev; 2011 Mar; 27(3):244-54. PubMed ID: 21309045
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and glycemic control in patients with type 2 diabetes.
El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
[TBL] [Abstract][Full Text] [Related]
11. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
Cook MN; Girman CJ; Stein PP; Alexander CM
Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
[TBL] [Abstract][Full Text] [Related]
13. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
[TBL] [Abstract][Full Text] [Related]
15. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.
Calvert MJ; McManus RJ; Freemantle N
Br J Gen Pract; 2007 Jun; 57(539):455-60. PubMed ID: 17550670
[TBL] [Abstract][Full Text] [Related]
16. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
[TBL] [Abstract][Full Text] [Related]
17. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
[TBL] [Abstract][Full Text] [Related]
18. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
[TBL] [Abstract][Full Text] [Related]
19. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
